Therapeutic approaches to children with enuresis: A retrospective study

Enuresis is a common pediatric condition and there are different treatment options. This study aimed to evaluate treatment options for enuresis in a sample of the child and adolescent psychiatry clinic. The data and treatment results of 98 patients (mean age: 10.38±2.15 years, range=6-16 years) diagnosed with enuresis between 1 May 2015 and 1 October 2020 were retrospectively reviewed. We found that 57 of the patients had previously applied to the hospital for enuresis, and 14 of them have applied to child and adolescent psychiatry, 10 of them to pediatric surgery, 20 of them to other branches of pediatrics, and 13 of them to the urology clinic. In previous hospital applications, behavioral treatment only had been applied to 40.4% of the patients, and pharmacotherapy had been applied in 59.6% of the patients. On the other hand, in the child and ado-lescent psychiatry clinic, 26.5% of the patients received behavioral treatment only, and 73.5% used drugs along with behavioral treatment, and the most frequently preferred drugs were imipramine (oftenest) and desmopressin. Also, the rates of psychiatric comorbidity in those who received medical treatment were significantly higher than those who treated behavioral treatment only. In conclusion, this study revealed that different clinical branches apply different treatment approaches to enuresis. In child and adolescent psychiatry, imipramine was the most commonly used agent in medical treatment, and this has been attributed to the high rate of psychiatric comorbidity

PDF

___

1. American, Psychiatric, Association. Diagnostic and statistical manual of mental disorders. DSM-5, American Psychiatric Association Publishing, 5th edition, 2013.

2. Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children’s Continence Society. Neu Uro. 2016;35:471-81.

3. Bayne AP, Skoog SJ. Nocturnal enuresis: an approach to assessment and treatment. Pediatr Rev. 2014;35:327‐35.

4. Arda E, Cakiroglu B, Thomas DT. Primary Nocturnal Enuresis: A Review. Nephrourol Mon. 2016;8:e35809.

5. Ring JI, Neveus T, Markstrom A, et al. Nocturnal enuresis impaired children’s quality of life and friendships. Acta Paediatr. 2017;106:806-11.

6. Sarici H, Telli O, Ozgur BC, et al. Prevalence of nocturnal enuresis and its influence on quality of life in school-aged children. J Pediatr Urol. 2016;12:159.1–6.

7. Van Herzeele C, De Bruyne P, De Bruyne E, et al. Challenging factors for enuresis treatment: psychological problems and non-adherence. J Pediatr Urol. 2015;11:308-13.

8. Uzun Çi̇çek A, Bora A, Altuntaş E. Adenoid hypertrophy and nocturnal enuresis are associated with sleep disturbances. ENT Updates. 2020;10:311- 20.

9. Caldwell PHY, Deshpande AV, Gontard AV. Management of nocturnal enuresis. BMJ. 2013;347:6259.

10. Neveus T, Eggert P, Evans J, et al. Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Childrenʼs Continence Society. J Urol. 2010;183:441‐47.

11. Oğraş MS, Ağlamiş E, Yücel MÖ, et al. Treatment and follow up results of patients with monosymptomatic enuresis nocturna. Dicle Med J. 2013;40:410-13.

12. Korgalı E. Enuresis Nocturna: Diagnosis and Evaluation. Turk Urol Sem. 2011;2:41-4.

13. Nevéus T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol. 2006;176:314-24.

14. Nevéus T, Fonseca E, Franco I, et al. Management and treatment of nocturnal enuresis an updated standardization document from the International Children's Continence Society. J Pediatr Urol. 2020;16:10-9.

15. Caldwell PH, Nankivell G, Sureshkumar P. Simple behavioural interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2013;7:CD003637.

16. Vande Walle J, Rittig S, Bauer S, et al. Practical consensus guidelines for the management of enuresis [published correction appears in Eur J Pediatr. 2012 Jun;171(6):1005] [published correction appears in Eur J Pediatr. 2013 Feb;172:285]. Eur J Pediatr. 2012;171:971-83.

17. Robson WLM, Leung AK. Urotherapy recommendations for betwetting. J Nati Med Assoc. 2002;94:577-80.

18. Hjalmas K, Arnold T, Bower W, et al. Nocturnal enuresis: an international evidence based management strategy. J Urol. 2004;171:2545–61.

19. Ramakrishnan K. Evaluation and treatment of enuresis. Am Fam Physician. 2008;78:489-96.

20. Glazener CM, Evans JH. Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev. 2002;CD002112.

21. Ghasemi K, Esteghamati M, Mohammadzadeh M, et al. Desmopressin versus Oxybutynin for Nocturnal Enuresis in Children in Bandar Abbas: A Randomized Clinical Trial. Electron Phy. 2016;8:2187-93.

22. Radvanska E, Kovács L, Rittig S. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis. J Urol. 2006;176:764-9.

23. Cendron M. Primary nocturnal enuresis: current concepts. Am Fam Phy.1999;59:1205–14,1219–20.

24. Glazener CM, Evans JH, Peto RE. Tricyclic and related drugs for nocturnal enuresis inchildren. Cochrane Database Syst Rev. 2003:CD002117.

25. Von Gontard A, Equit M. Comorbidity of ADHD and incontinence in children. Eur Child Adolesc Psychiatry. 2015;24:127–40.

26. Fritz G, Rockney R. Practice parameter for the assessment and treatment of children andadolescents with enuresis. J Am Acad Child Adolesc Psychiatry. 2004;43:1540-50.